Lin et al. confirmed the suppressive role of STK4 in breast cancer, emphasizing that its low levels were associated with reduced patient survival [24] and proposed its utility as a prognostic and predictive biomarker, as well as a therapeutic target [25]. This evidence concerns the gene STK4 and breast carcinoma.